Literature DB >> 2048594

The fetal concentrating index as a gestational age-independent measure of placental dysfunction in intrauterine growth retardation.

I Bernardini1, M I Evans, K H Nicolaides, D L Economides, W A Gahl.   

Abstract

In previous work we have shown, using cordocentesis to obtain fetal blood, that fetuses with intrauterine growth retardation are hypoxic and suffer from in utero starvation of nutrients. In this study we have developed gestational age curves for fetal blood amino acids and carnitine that now allow the development of a new parameter, the fetal concentrating index, which is the numeric mean of the fetal/maternal ratio of six essential and nonessential concentrated amino acids. Our data have shown that this index does not vary with gestation in either normal pregnancies (1.83 +/- 0.42, mean +/- SD) or pregnancies with intrauterine growth retardation (1.46 +/- 0.38), but the index is markedly reduced in intrauterine growth retardation (p less than 0.001). These results suggest that, because cordocentesis has become very safe in experienced hands, cordocentesis to obtain the fetal concentrating index might ethically be obtained in cases of fetuses at risk for intrauterine growth retardation, to devise strategies for intervention before the onset of severe hypoxia and morphometric changes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2048594     DOI: 10.1016/0002-9378(91)91427-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Adverse birth outcomes in a malarious area.

Authors:  B F Kalanda; F H Verhoeff; L Chimsuku; G Harper; B J Brabin
Journal:  Epidemiol Infect       Date:  2005-10-28       Impact factor: 2.451

2.  Distribution of fentanyl in the placental intervillous space and in the different maternal and fetal compartments in term pregnant women.

Authors:  Luciana de Barros Duarte; Elaine Cristine Dantas Moisés; Ricardo Carvalho Cavalli; Vera Lúcia Lanchote; Geraldo Duarte; Sérgio Pereira da Cunha
Journal:  Eur J Clin Pharmacol       Date:  2009-03-28       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.